Journal of Nuclear Cardiology

, Volume 19, Issue 3, pp 465–473 | Cite as

Transient ischemic dilation for coronary artery disease in quantitative analysis of same-day sestamibi myocardial perfusion SPECT

  • Yuan Xu
  • Reza Arsanjani
  • Morgan Clond
  • Mark Hyun
  • Mark LemleyJr
  • Mathews Fish
  • Guido Germano
  • Daniel S. Berman
  • Piotr J. SlomkaEmail author
Original Article



Transient ischemic dilation (TID) of the left ventricle in myocardial perfusion SPECT (MPS) has been shown to be a clinically useful marker of severe coronary artery disease (CAD). However, TID has not been evaluated for 99mTc-sestamibi rest/stress protocols (Mibi-Mibi). We aimed to develop normal limits and evaluate diagnostic power of TID ratio for Mibi-Mibi scans.


TID ratios were automatically derived from static rest/stress MPS (TID) and gated rest/stress MPS from the end-diastolic phase (TIDed) in 547 patients who underwent Mibi-Mibi scans [215 patients with correlating coronary angiography and 332 patients with low likelihood (LLk) of CAD]. Scans were classified as severe (≥70% stenosis in proximal left anterior descending (pLAD) artery or left main (LM), or ≥90% in ≥2 vessels), mild to moderate (≥90% stenosis in 1 vessel or ≥70%-90% in ≥1 vessel except pLAD or LM), and normal (<70% stenosis or LLk group). Another classification based on the angiographic Duke prognostic CAD index (DI) was also applied: DI ≥ 50, 30 ≤ DI < 50 and DI < 30 or LLk group.


The upper normal limits were 1.19 for TID and 1.23 for TIDed as established in 259 LLk patients. Both ratios increased with disease severity (P < .0001). Incidence of abnormal TID increased from 2% in normal patients to >36% in patients with severe CAD. Similarly, when DI was used to classify disease severity, the average ratios showed significant increasing trend with DI increase (P < .003); incidence of abnormal TID also increased with increasing DI. The incidence of abnormal TID in the group with high perfusion scores significantly increased compared to the group with low perfusion scores (stress total perfusion deficit, TPD < 3%) (P < .0001). The sensitivity for detecting severe CAD improved for TID when added to mild to moderate perfusion abnormality (3% ≤ TPD < 10%): 71% vs 64%, P < .05; and trended to improve for TIDed/TIDes: 69% vs 64%, P = .08, while the accuracy remained consistent if abnormal TID was considered as a marker in addition to stress TPD. Similar results were obtained when DI was used for the definition of severe CAD (sensitivity: 76% vs 66%, P < .05 when TID was combined with stress TPD).


TID ratios obtained from gated or ungated Mibi-Mibi MPS and are useful markers of severe CAD.


Single photon emission computed tomography myocardial perfusion imaging sestamibi transient ischemic dilation 



This research was supported in part by Grant R0HL089765 from the National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH) (PI: Piotr Slomka). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NHLBI. We would like to thank Arpine Oganyan for editing and proof-reading the text.


  1. 1.
    Weiss AT, Berman DS, Lew AS, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.PubMedCrossRefGoogle Scholar
  2. 2.
    Chouraqui P, Rodrigues EA, Berman DS, Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990;66:689-94.PubMedCrossRefGoogle Scholar
  3. 3.
    Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.PubMedCrossRefGoogle Scholar
  4. 4.
    Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612-20.PubMedCrossRefGoogle Scholar
  5. 5.
    Bestetti A, Di Leo C, Alessi A, Triulzi A, Tagliabue L, Tarolo GL. Post-stress end-systolic left ventricular dilation: A marker of endocardial post-ischemic stunning. Nucl Med Commun 2001;22:685-93.PubMedCrossRefGoogle Scholar
  6. 6.
    McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.PubMedCrossRefGoogle Scholar
  7. 7.
    Abidov A, Bax JJ, Hayes SW, Cohen I, Gerlach J, Kang X, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818-25.PubMedCrossRefGoogle Scholar
  8. 8.
    Abidov A, Germano G, Berman DS. Transient ischemic dilation ratio: A universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol 2007;14:497-500.PubMedCrossRefGoogle Scholar
  9. 9.
    Germano G, Berman DS. Clinical gated cardiac SPECT. Malden, MA: Blackwell; 2006.CrossRefGoogle Scholar
  10. 10.
    Abidov A, Berman DS. Transient ischemic dilation associated with poststress myocardial stunning of the left ventricle in vasodilator stress myocardial perfusion SPECT: True marker of severe ischemia? J Nucl Cardiol 2005;12:258-60.PubMedCrossRefGoogle Scholar
  11. 11.
    Valdiviezo C, Motivala AA, Hachamovitch R, Chamarthy M, Navarro PC, Ostfeld RJ, et al. The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images. J Nucl Cardiol 2011;18:220-9.PubMedCrossRefGoogle Scholar
  12. 12.
    Mandour Ali MA, Bourque JM, Allam AH, Beller GA, Watson DD. The prevalence and predictive accuracy of quantitatively defined transient ischemic dilation of the left ventricle on otherwise normal SPECT myocardial perfusion imaging studies. J Nucl Cardiol 2011;18:1036-43.PubMedCrossRefGoogle Scholar
  13. 13.
    Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45:1999-2007.PubMedGoogle Scholar
  14. 14.
    Takeishi Y, Tono-oka I, Ikeda K, Komatani A, Tsuiki K, Yasui S. Dilatation of the left ventricular cavity on dipyridamole thallium-201 imaging: A new marker of triple-vessel disease. Am Heart J 1991;121:466-75.PubMedCrossRefGoogle Scholar
  15. 15.
    Veilleux M, Lette J, Mansur A, Bertrand C, Cerino M, Picard M, et al. Prognostic implications of transient left ventricular cavitary dilation during exercise and dipyridamole-thallium imaging. Can J Cardiol 1994;10:259-62.PubMedGoogle Scholar
  16. 16.
    McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997;79:600-5.PubMedCrossRefGoogle Scholar
  17. 17.
    Xu Y, Fish M, Gerlach J, Lemley M, Berman DS, Germano G, et al. Combined quantitative analysis of attenuation corrected and non-corrected myocardial perfusion SPECT: Method development and clinical validation. J Nucl Cardiol 2010;17:591-9.PubMedCrossRefGoogle Scholar
  18. 18.
    Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.PubMedCrossRefGoogle Scholar
  19. 19.
    Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994;89:2015-25.PubMedGoogle Scholar
  20. 20.
    Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47.PubMedGoogle Scholar
  21. 21.
    Hambye AS, Vervaet A, Dobbeleir A. Variability of left ventricular ejection fraction and volumes with quantitative gated SPECT: Influence of algorithm, pixel size and reconstruction parameters in small and normal-sized hearts. Eur J Nucl Med Mol Imaging 2004;31:1606-13.PubMedCrossRefGoogle Scholar
  22. 22.
    Berman DS, Kang X, Gransar H, Gerlach J, Friedman JD, Hayes SW, et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol 2009;16:45-53.PubMedCrossRefGoogle Scholar
  23. 23.
    Kritzman JN, Ficaro EP, Corbett JR. Post-stress LV dilation: The effect of imaging protocol, gender and attenuation correction [abstract]. J Nucl Med 2001;42:50P.Google Scholar
  24. 24.
    Emmett L, Van Gaal WJ, Magee M, Bass S, Ali O, Freedman SB, et al. Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging. J Nucl Cardiol 2008;15:638-43.PubMedCrossRefGoogle Scholar
  25. 25.
    Heston TF, Sigg DM. Quantifying transient ischemic dilation using gated SPECT. J Nucl Med 2005;46:1990-6.PubMedGoogle Scholar
  26. 26.
    Hung GU, Lee KW, Chen CP, Lin WY, Yang KT. Relationship of transient ischemic dilation in dipyridamole myocardial perfusion imaging and stress-induced changes of functional parameters evaluated by Tl-201 gated SPECT. J Nucl Cardiol 2005;12:268-75.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2012

Authors and Affiliations

  • Yuan Xu
    • 1
  • Reza Arsanjani
    • 1
  • Morgan Clond
    • 1
    • 2
  • Mark Hyun
    • 1
  • Mark LemleyJr
    • 3
  • Mathews Fish
    • 3
  • Guido Germano
    • 1
    • 4
  • Daniel S. Berman
    • 1
  • Piotr J. Slomka
    • 1
    • 4
    Email author
  1. 1.Departments of Imaging and MedicineCedars-Sinai Medical CenterLos AngelesUSA
  2. 2.Cedars Sinai Graduate Program in Biomedical Science and Translational MedicineLos AngelesUSA
  3. 3.Oregon Heart and Vascular Institute, Sacred Heart Medical CenterSpringfieldUSA
  4. 4.David Geffen School of MedicineUniversity of California, Los AngelesLos AngelesUSA

Personalised recommendations